Yaazh Xenomics delivers advanced medical genomics services in India from our ISO-certified lab in Coimbatore, Tamil Nadu. We specialize in whole exome sequencing (WES), clinical exome sequencing, cancer genetic panels, pharmacogenomics (PGx) testing, hereditary disease panels, and targeted sequencing – empowering precise diagnostics, personalized treatment, and preventive care for rare diseases, oncology, and drug response.
As a trusted clinical genomics partner, we combine cutting-edge NGS platforms (Illumina NovaSeq, Oxford Nanopore, Thermo) with expert bioinformatics to provide actionable genetic insights at affordable prices across India.
Medical genomics uses Next-Generation Sequencing (NGS) to analyze an individual's DNA for disease-causing variants, predispositions, and drug responses. Key types include:
These tests enable personalized medicine: early detection, tailored therapies, reduced adverse drug reactions, and improved outcomes.
For broader analysis, explore our Whole Genome Sequencing or Exome Sequencing pages.
Genomic testing has emerged as a revolutionary approach in the field of medicine, providing critical insights that enhance patient care through personalized strategies.The primary types of genomic testing include whole exome sequencing, clinical exome sequencing, blended genome sequencing, and whole human genome sequencing, each serving unique purposes within diagnostics and patient care.
Whole exome sequencing focuses exclusively on the protein-coding regions of the genome, constituting approximately 1% of the total DNA but holding a major role in determining phenotypic traits. This method is particularly valuable for identifying genetic mutations associated with various hereditary diseases.
Clinical exome sequencing, on the other hand, is a refined version, integrating targeted regions that are most clinically relevant. This offers a more streamlined approach compared to whole exome sequencing, making it ideal for conditions where a panel of known mutations can expedite diagnosis.
Blended genome sequencing combines aspects of both targeted and whole exome sequencing, enabling clinicians to assess both common variants and rarer mutations. This versatility enhances its application in complex diseases that may arise from multiple genetic factors.
Lastly, whole human genome sequencing provides a comprehensive analysis of an individual's entire genomic makeup. While it offers the broadest scope for research and clinical insights, the sheer complexity involved often requires advanced interpretation and may not yet be practical for everyday clinical use. The significance of these medical genomics testing services lies in their ability to facilitate tailored treatment strategies, empowering healthcare providers with actionable genetic insights. This approach not only aids in disease prevention but also enhances therapeutic efficacy, marking a substantial shift toward a more personalized and precise medical landscape.
Among the myriad services offered by Yaazh Xenomics, two noteworthy applications include cancer screening and pharmacogenomics (PGx) panel testing. These tests not only identify genetic mutations but also serve as proactive tools in tailoring treatment plans based on individual genetic profiles.
Cancer screening through genomic testing allows for the early detection of hereditary cancer syndromes, which can significantly influence patient management. For instance, tests can reveal mutations inspecific genes, such as BRCA1 and BRCA2, which are associated with a higher risk of breast cancers. By understanding one’s genetic predisposition, healthcare providers can recommend preventive measures, monitor at-risk patients more closely, and devise personalized therapeutic options aimed at improving survival outcomes.
Pharmacogenomics (PGx) testing represents another pivotal aspect of genomic services, focusing on how genetic variations influence an individual's response to medications. This approach enables physicians to avoid trial-and-error prescriptions, thereby reducing adverse drug reactions and enhancing therapeutic efficacy. For example, PGx testing can inform dosage adjustments for anesthetics, antidepressants, and anticoagulants, aligning treatments with the patient's unique genetic makeup to optimize results.
Contact Coimbatore’s leading clinical genomics lab for personalized genetic insights today.
Yaazh Xenomics Pvt Ltd
Module No. 103, TICEL BIOPARK Phase – III,
Maruthamalai Road, Coimbatore – 641046, Tamil Nadu, India
Phone: +91 99431 32020 | +91 95002 45454
Email: info@yaazhxenomics.com
Request Quote | All NGS Services
Yaazh Xenomics – Precision Genomics for Personalized Healthcare in India.
Yaazh Xenomics is a leading biotechnology company based in Coimbatore, Tamil Nadu, India, specializing in comprehensive genomic solutions. As a DNA testing laboratory, we offer a broad spectrum of services, including DNA sequencing, RNA Sequencing, Sanger Sequencing, 16s rRNA, 18s rRNA, ITS, COI, RBCL, Matk gene Sequencing for DNA Barcoding, gene expression analysis, SNP analysis, Next-Generation Sequencing (NGS), Various Medical Genome testing, Exome Sequencing, Gut Microbiome Test, Metagenome Sequencing, Whole Genome Sequencing (WGS), Transcriptome Sequencing using advance NGS platforms like Nanopore, Illumina, MGI, Thermo. Also, we provide advance Bioinformatics, Customized Bioinformatics and a variety of other genetic testing and Molecular testing.